Table 1.
Host and viral factors associated with the natural course of chronic hepatitis B virus (HBV) infection
Clinical events | Associate factors | References |
---|---|---|
Hepatitis B e antigen (HBeAg) seroconversion | Host factors | |
Puberty onset | [19, 20] | |
Steroid 5-alpha reductase type II | [19] | |
Dehydroepiandrosterone sulphate | [26] | |
Human leukocyte antigen (HLA)-B61 and HLA-DQB1*0503 | [39] | |
Interleukin-10 and 12 | [42] | |
Toll-like receptor-5 and -9 | [43] | |
Furin | [68, 69] | |
Program death 1 and program death ligand-1 pathway | [46, 48, 70] | |
Virus factors | ||
HBV Genotype | [40–52] | |
HBV mutant strains (core-promotor, precore, core gene) | [54, 57, 58, 67] | |
HBV viral load | [26] | |
HBV viral titer decrement | Host factors | |
Puberty onset | [19] | |
Dehydroepiandrosterone sulphate | [26] | |
Virus factors | ||
HBV mutant strains (core-promotor, precore, core gene) | [54, 57, 58, 67] | |
Hepatitis B surface antigen (HBsAg) seroclearance/seroconversion | Host factors | |
Dehydroepiandrosterone sulphate | [26] | |
Gut microbiota | [47] | |
Menarche onset (in females) | [20] | |
HLA (DRB1*1301-02, DR2, DR7, DR*0406, B*4001, DPA1 and DPB1) | [33–38] | |
Interleukin-10 and 12 | [45] | |
Tumor necrosis factor alpha | [41] | |
Toll-like receptor-4 | [43, 47] | |
Program death 1 and program death ligand-1 pathway | [46, 48, 70] | |
Breakthrough of immune tolerance | [45] | |
HBeAg seroconversion at childhood | [45] | |
Virus factors | ||
HBV viral load | [45] | |
HBsAg titer | [45] | |
HBeAg-negative hepatitis | HBeAg seroconversion age | [10–12, 60, 75] |
HBV mutant | [57, 75] |